News

In a startling figure, multidrug-resistant bacteria kill almost 5 million people every year, with newly resistant germs emerging faster than the scientists can actually develop the treatments. The researchers have now gone on to develop a platform which can go ahead...

In an industry driven by both compliance and consumer confidence, pharmaceutical and nutraceutical brands are increasingly turning toward robust and reusable packaging alternatives. One solution gaining significant traction is the custom medicine tin container—a durable, FDA-compliant packaging form that...

In order to treat multiple myeloma in adults, Sarclisa from Sanofi in combination with a regimen of lenalidomide, bortezomib, and dexamethasone (VRd) has been granted approval by the European Commission. It is well to be noted that Sarclisa has received...

The European Union is going to pay the US a tariff rate of 15% when it comes to pharmaceutical products as part of a new trade deal between the two countries, although there are uncertainties looming on the future...

Finally, the Trump administration’s much-animated tariffs on pharmaceutical imports are now materializing in a new EU-US trade deal. However, there are still many questions that remain. As part of a trade agreement that was reached between the US and the...

In a recent move, Hengrui Pharma and GSK have inked an agreement when it comes to the development of almost 12 innovative medicines throughout several therapeutic areas, which include immunology, inflammation, oncology, and respiratory. This partnership is all set to...

A legislation to decentralize personalized drug manufacturing in UK has been passed, enabling them to be prepared across facilities, which are closer to the patient. This recent legislation, which has been passed, which is the Human Medicine Regulations 2025, goes on...